| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/13/2014 | WO2014025001A1 Method for labelling of cleavage of nucleic acid sequence |
| 02/13/2014 | WO2014024853A1 Pivka-ii measurement method, measurement reagent, and measurement kit |
| 02/13/2014 | WO2014024820A1 Pharmaceutical composition for treating new chronic kidney disease and method for screening medicine for new chronic kidney disease |
| 02/13/2014 | WO2014024598A1 Biomolecule detection method, biomolecule detection device and analysis device |
| 02/13/2014 | WO2014024157A1 Plasma separation using a drop of blood |
| 02/13/2014 | WO2014024106A1 Method for the production of thermochemiluminescent silica nanoparticles and their use as markers in bioanalytic methods |
| 02/13/2014 | WO2014024066A1 Method and apparatus for separating plasma from blood for bilirubin level estimation. |
| 02/13/2014 | WO2014024041A1 Method and kit for nucleic acid sequencing |
| 02/13/2014 | WO2014023984A2 Method for the direct detection of mycobacterium tuberculosis |
| 02/13/2014 | WO2014023957A2 Anti-tumour response to modified self-epitopes |
| 02/13/2014 | WO2014023952A2 Prevention and treatment of osteoarthritis |
| 02/13/2014 | WO2014023947A1 Method for identifying a specific binding interaction between two or more polypeptides |
| 02/13/2014 | WO2014023852A1 Biomarkers |
| 02/13/2014 | WO2014023827A1 Novel far red fluorescent protein |
| 02/13/2014 | WO2014023820A1 Diagnostic of heart failure |
| 02/13/2014 | WO2014023819A1 Methods for predicting the survival time of a patient suffering from a glioblastoma |
| 02/13/2014 | WO2014023808A2 Method for evaluating a cancer patient for propensity to respond to a therapy |
| 02/13/2014 | WO2014023765A2 Method and separation device for separating a filtrate from a sample fluid |
| 02/13/2014 | WO2014023761A1 Multi-part device for extracting plasma from blood |
| 02/13/2014 | WO2014023756A1 Plasma separation system and method for plasma separation |
| 02/13/2014 | WO2014023655A1 Immunoassay-based determination of in-solution binding kinetics |
| 02/13/2014 | WO2014023612A1 Composition and use of substances for the in vitro stabilization of glucose, lactate and homocysteine in blood |
| 02/13/2014 | WO2014023436A1 Method and reagents for the quantification of the lipid phosphatidylinositol 3 monophosphate |
| 02/13/2014 | WO2014023283A1 Surface treatment process for components composed of aluminium having detection of impermissible overheating |
| 02/13/2014 | WO2013190075A9 Specific biomarkers for hepatocellular carcinoma (hcc) |
| 02/13/2014 | WO2013188767A8 Method and system for measuring the pharmacokinetics of liposomal curcumin and its metabolite tetrahydrocurcumin |
| 02/13/2014 | WO2013185134A3 Blood biomarkers for necrotizing enterocolitis |
| 02/13/2014 | WO2013040142A3 Bioinformatic processes for determination of peptide binding |
| 02/13/2014 | WO2012001633A3 Apparatus for the measurement of the gas concentration in a sealed container |
| 02/13/2014 | US20140047572 Thrombopoietin mimetics for the treatment of radiation or chemical induced bone marrow injury |
| 02/13/2014 | US20140046640 Telenostics for medical uses |
| 02/13/2014 | US20140046600 Sim card based medical testing and data transmission system |
| 02/13/2014 | US20140046052 Therapeutic Sulfated Polysaccharides, Compositions Thereof, and Methods for Treating Patients |
| 02/13/2014 | US20140045920 Methods and compositions for the diagnosis, classification, and treatment of cancer |
| 02/13/2014 | US20140045897 Use of bubr1 as a biomarker of drug response to furazanobenzimidazoles |
| 02/13/2014 | US20140045883 Ack1 kinase inhibition to treat triple negative breast cancer |
| 02/13/2014 | US20140045875 Fused and Spirocycle Compounds and the Use Thereof |
| 02/13/2014 | US20140045743 Compositions and methods for coronavirus inhibition |
| 02/13/2014 | US20140045740 Analysis of glatiramer acetate |
| 02/13/2014 | US20140045727 Polymer Conjugate Enhanced Bioassays |
| 02/13/2014 | US20140045724 Formulation screening methods, apparatuses for performing such methods and formulations formed by such methods |
| 02/13/2014 | US20140045721 Microarray System and a Process for Producing Microarrays |
| 02/13/2014 | US20140045719 Directed synthesis of oligophosphoramidate stereoisomers |
| 02/13/2014 | US20140045718 Biomarkers for inflammation of the liver |
| 02/13/2014 | US20140045715 Tivozanib response prediction |
| 02/13/2014 | US20140045714 Novel Biomarkers For Cardiovascular Injury |
| 02/13/2014 | US20140045713 Biomarkers of brain injury |
| 02/13/2014 | US20140045277 System for trapping, interacting and modifying single protein molecules using a double-nanohole structure |
| 02/13/2014 | US20140045276 Assays for detecting autoantibodies to anti-tnfalpha drugs |
| 02/13/2014 | US20140045270 Device having nanopore with thiol-containing material attached to gold layer and method of analyzing nucleic acid using the device |
| 02/13/2014 | US20140045251 Sequential analysis of biological samples |
| 02/13/2014 | US20140045207 Compositions and methods for modification of biomolecules |
| 02/13/2014 | US20140045204 Evaluation of copolymer diethylamide |
| 02/13/2014 | US20140045202 Analyte Sensors and Methods for Making and Using the Same |
| 02/13/2014 | US20140045201 Method for quantifying cholesterol in high-density lipoprotein 2, and reagent kit for the method |
| 02/13/2014 | US20140045200 Predicting mortality and detecting severe disease |
| 02/13/2014 | US20140045199 Anti-ve-cadherin autoantibodies as a biomarker of vascular alterations associated with disorders |
| 02/13/2014 | US20140045198 Method of predicting the evolution of a patient suffering of stroke |
| 02/13/2014 | US20140045197 Biomarkers used to detect and monitor neurological autoimmune diseases |
| 02/13/2014 | US20140045196 Methods of prognosis and diagnosis of cancer |
| 02/13/2014 | US20140045193 Methionine metabolites predict aggressive cancer progression |
| 02/13/2014 | US20140045192 Single-stranded nucleic acid aptamers specifically binding to e. coli and method for detecting e. coli using the same |
| 02/13/2014 | US20140045172 Dual Path Immunoassay Device |
| 02/13/2014 | US20140045170 Methods for detecting and measuring aggregation |
| 02/13/2014 | US20140045169 Glycan immobilized metal nanoparticles and use thereof for early hiv-1 detection |
| 02/13/2014 | US20140044796 Detection and removal of misfolded proteins/peptides |
| 02/13/2014 | US20140044770 Compositions and Methods for Modulating BRD4 Bioactivity |
| 02/13/2014 | US20140044741 B-type plexin antagonists and uses thereof |
| 02/13/2014 | US20140044740 Diagnostic and Therapeutic Targets for Leukemia |
| 02/13/2014 | US20140044738 Antibodies And Other Molecules That Bind B7-H1 And PD-1 |
| 02/13/2014 | US20140044737 Rbp4 in insulin sensitivity/resistance, diabetes, and obesity |
| 02/13/2014 | US20140044735 Methods to characterize patients suffering from hemolysis |
| 02/13/2014 | US20140044733 Antibody based reagent that specifically recognizes toxic oligomeric form of beta-amyloid |
| 02/13/2014 | US20140044731 Methods of treating age-related macular degeneration |
| 02/13/2014 | US20140044729 Antibody and antigen recognizing tumor-initiating cells and use thereof |
| 02/13/2014 | US20140044728 Anti-tim-3 antibody |
| 02/13/2014 | US20140044720 Human monoclonal antibodies that bind insulin-like growth factor (igf) i and ii |
| 02/13/2014 | US20140044714 Human monoclonal antibodies specific for glypican-3 and use thereof |
| 02/13/2014 | US20140044713 Compounds |
| 02/13/2014 | US20140044710 Von willebrand factor specific binders and methods of use therefor |
| 02/13/2014 | US20140044702 Diagnosis and treatments relating to th2 inhibition |
| 02/13/2014 | US20140044696 Methods for culturing stem and progenitor cells |
| 02/13/2014 | US20140044681 Cathepsin K As A Marker For Cartilage Production, Repair and Regeneration |
| 02/13/2014 | US20140044673 Classifying Skin Lesions Using Mass Spectrometry Proteomic Approach |
| 02/13/2014 | US20140044645 Diagnosis and treatments relating to th2 inhibition |
| 02/13/2014 | US20140044644 Ankyrin g and modulators thereof for the treatment of neurodegenerative disorders |
| 02/13/2014 | US20140044643 Magnetic Calcium Phosphate Nanoparticles, Applications And Methods Of Preparation Thereof |
| 02/13/2014 | US20140044641 Polypeptides and polynucleotides, and uses thereof for treatment of immune related disorders and cancer |
| 02/13/2014 | US20140043488 System and Method for Drug Detection Using SWIR |
| 02/13/2014 | US20140043011 Gem Tester |
| 02/13/2014 | US20140041905 Surfaces having particles and related methods |
| 02/13/2014 | US20140041532 Logistic Transport System for Nutritional Substances |
| 02/13/2014 | US20140041445 Apparatus for measuring drying rate and method for measuring drying rate using the same |
| 02/13/2014 | US20140041443 Analysis system having a measurement device and test element |
| 02/13/2014 | US20140041441 Method and Apparatus for Providing Data Processing and Control in a Medical Communication System |
| 02/13/2014 | US20140041440 Fluid storage and dispensing system including dynamic fluid monitoring of fluid storage and dispensing vessel |
| 02/13/2014 | US20140041436 Breath alcohol tester calibration station |
| 02/13/2014 | DE202013010433U1 Neues Reagenz New reagent |
| 02/13/2014 | DE102012215913B3 Device for simulation of naturalistic stressing of quality of strand of hair, has control unit for controlling drive unit and other parameters, where frame-fixed station adjusts specific stressing of defined hair feature |
| 02/13/2014 | DE102012214317A1 System for determining deformation characteristic values of ground, has test device for determining deformation characteristic value, and measurement evaluation unit with control unit for evaluating data and initializing measuring operation |